Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings.
Abstract This study explores the perception of and readiness for hepatitis C treatment within a sample of 77 clients already participating in drug treatment, with a view to identifying likely barriers and incentives to hepatitis C treatment within a drug treatment population. Participants with hepatitis C did...

StemCells Wins NIH Grant to Pursue Cell-Based Therapeutic for Hepatitis C.
HEALTH AND BEAUTY CLOSE-UP-9 October 2008-StemCells Wins NIH Grant to Pursue Cell-Based Therapeutic for Hepatitis C(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com StemCells announced that it has been awarded a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential...

Pro-Pharmaceuticals Elects Scott Friedman, M.D., to Its Scientific Advisory Board.
HEALTH AND BEAUTY CLOSE-UP-16 July 2008-Pro-Pharmaceuticals Elects Scott Friedman, M.D., to Its Scientific Advisory Board(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Pro-Pharmaceuticals, a company developing proprietary carbohydrate-based therapeutic compounds to treat serious diseases such as cancer and fibrosis, has named Scott L. Friedman, M.D., to its Scientific Advisory Board....

Sucampo Pharmaceuticals Starts Phase 2 Trial for the Treatment of Portal Hypertension.
HEALTH AND BEAUTY CLOSE-UP-31 July 2008-Sucampo Pharmaceuticals Starts Phase 2 Trial for the Treatment of Portal Hypertension(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Sucampo Pharmaceuticals announced that it has enrolled its first patient in a single-center Phase 2 trial evaluating its clinical stage compound, cobiprostone, for the treatment of...

OBITUARIES.
Byline: The Register-Guard John Bobb Sr. A celebration of life will be from 1 p.m. to 4 p.m. Saturday, Sept. 13, at 3645 Countryside Lane in Eugene for John E. Bobb Sr. of Eugene. He died Aug. 26 of cancer at age 60. ...

iTherX Pharmaceuticals Forms Scientific and Clinical Advisory Board.
HEALTH AND BEAUTY CLOSE-UP-22 August 2008-iTherX Pharmaceuticals Forms Scientific and Clinical Advisory Board(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com iTherX Pharmaceuticals, a privately held biopharmaceutical company, announced that it has appointed a Scientific and Clinical Advisory Board to assist the company in the development of its novel therapeutic agents...

OBITUARIES.
Byline: The Register-Guard Orland Axton SPRINGFIELD - The funeral will be held at 2 p.m. today, Sept. 10, at Lane Memorial Gardens & Funeral Home in Eugene for Orland H. Axton of Springfield. He died Sept. 7 of age-related causes at age 87. Visitation will...

Premature recommendations.
It must be possible to be excited and uncomfortable at the same time, because I cringed when I read a recent article based on a presentation by Dr. Dana E. King of the Medical University of South Carolina, Charleston ("Taking Up Moderate Drinking Slashes CV Risk," April 15, 2008,...

New state life-sci center awards $3.1M in grants.
Byline: John J. Monahan BOSTON - The state's new Life Sciences Center awarded its first round of research and development grants yesterday and announced that the state's new stem-cell registry at the University of Massachusetts Medical School will be ready to open next month. The...

Risk factors predict acetaminophen hepatotoxicity.
Patients hospitalized for acetaminophen overdose had a 4.5% rate of acetaminophen-induced hepatotoxicity in a population-based study, according to Dr. Robert P Myers and his associates. In a multivariate analysis of residents of Calgary and southern Alberta (Canada) during 1995-2004, significant risk factors for acetaminophen hepatotoxicity were alcohol...